We are live on ! Find out more
TNYA icon

Tenaya Therapeutics
TNYA

64 hedge funds and large institutions have $128M invested in Tenaya Therapeutics in 2023 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 12 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 12

35% more capital invested

Capital invested by funds: $94.7M → $128M (+$33.6M)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

6% less funds holding

Funds holding: 68 → 64 (-4)

6.36% less ownership

Funds ownership: 73.64% → 67.28% (-6.4%)

27% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 15

69% less call options, than puts

Call options by funds: $70K | Put options by funds: $224K

Holders
64
Holders Change
-4
Holders Change %
-5.88%
% of All Funds
1.02%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
11
Increased
27
Reduced
12
Closed
15
Calls
$70K
Puts
$224K
Net Calls
-$154K
Net Calls Change
-$90K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$2.61M
2
BlackRock
BlackRock
New York
+$1.47M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$885K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$706K
5
Northern Trust
Northern Trust
Illinois
+$351K

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$4.94M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$2.08M
3
ROTUOC
Regents of the University of California
California
-$1.87M
4
Blackstone Inc
Blackstone Inc
New York
-$643K
5
Walleye Capital
Walleye Capital
New York
-$410K
Name Holding Trade Value Shares
Change 		Change in
Stake
CG
1
Column Group
California
$26.8M – – –
CC
2
Casdin Capital
New York
$17.3M – – –
RCM
3
RA Capital Management
Massachusetts
$17.3M – – –
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$12.5M -$240K -85,419 -2%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$10.7M +$2.61M +929,820 +33%
BlackRock
6
BlackRock
New York
$7.94M +$1.47M +524,792 +23%
Vanguard Group
7
Vanguard Group
Pennsylvania
$5.32M +$706K +251,411 +16%
T. Rowe Price Investment Management
8
T. Rowe Price Investment Management
Maryland
$4.46M -$618 -220 -0%
Citadel Advisors
9
Citadel Advisors
Florida
$3.13M -$92.7K -32,991 -3%
ROTUOC
10
Regents of the University of California
California
$2.74M -$1.87M -665,793 -41%
AI
11
Alphabet Inc
California
$2.61M – – –
EC
12
Euclidean Capital
New York
$2.61M – – –
Geode Capital Management
13
Geode Capital Management
Massachusetts
$2.25M +$885K +315,046 +66%
HMC
14
Harvard Management Company
Massachusetts
$1.92M – – –
State Street
15
State Street
Massachusetts
$1.42M +$196K +69,708 +16%
SG
16
StepStone Group
California
$1.32M – – –
Northern Trust
17
Northern Trust
Illinois
$992K +$351K +124,832 +56%
TOCUITCONY
18
Trustees of Columbia University in the City of New York
New York
$832K – – –
Renaissance Technologies
19
Renaissance Technologies
New York
$755K +$157K +55,821 +27%
BCM
20
Bridgeway Capital Management
Texas
$518K +$224K +79,600 +78%
Millennium Management
21
Millennium Management
New York
$458K +$136K +48,415 +43%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$365K +$146K +52,000 +68%
Two Sigma Investments
23
Two Sigma Investments
New York
$338K +$108K +38,505 +48%
TD Asset Management
24
TD Asset Management
Ontario, Canada
$328K – – –
Charles Schwab
25
Charles Schwab
California
$322K +$145K +51,632 +84%
1
2 3 4

TNYA Hedge Fund Activity: Q1 2023 in Review

64 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q1 2023, worth a combined $128M — up 35% from $94.7M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of TNYA and 11 opened new positions — a net loss of 4 holders — while 12 trimmed existing stakes and 27 added.

The largest buyer was Fidelity Investments, adding an estimated $2.61M. The largest seller was RTW Investments, exiting entirely with an estimated $4.94M sold.

  • 64 institutional investors held Tenaya Therapeutics (TNYA) as of Q1 2023, down from 68 in Q4 2022.
  • Funds reported $128M of Tenaya Therapeutics stock for Q1 2023, up 35% quarter-over-quarter.
  • 11 funds opened new Tenaya Therapeutics positions in Q1 2023 and 15 closed out, a net change of -4 holders.
  • The largest Tenaya Therapeutics buyer in Q1 2023 was Fidelity Investments, an estimated $2.61M added.
  • The largest Tenaya Therapeutics seller in Q1 2023 was RTW Investments, an estimated $4.94M sold.

Based on aggregated 13F filings for Q1 2023.